Abstract
The study was performed to compare whole-body short time inversion recovery (STIR) MR imaging and 99mTc-methylene diphosphonate planar scintigraphy in the examination of children with suspected multifocal skeletal malignant lesions. Sixteen patients with known or suspected malignant skeletal disease underwent both whole-body STIR MR imaging and bone scintigraphy. The lesions were described and numbered according to scintigraphic evaluation criteria. Thus, 16 regions were analyzed in each patient for the comparison between the two modalities. Histology was proven in the primary malignant regions. Follow-up MRIs were registered. Scintigraphy and MRI follow-up were evaluated as gold standard. A total of 139 different lesions was observed by both modalities. Baseline whole-body MRI revealed 119 bone lesions in 256 possible sites (46.5%); scintigraphy revealed only 58 lesions (22.6%). Congruence was observed in only four patients (25%). According to the location of the lesion, correlation was observed in 39/139 lesions (28%). In all, 57.5% of the lesions were detected only by MRI and 14.5% of the lesions were detected only by scintigraphy. Whole-body MRI was more sensitive (P<0.001). Of all lesions numbered which could be separated in the initial MRI, whole-body MRI detected 178 lesions in the patients. The results suggest that whole-body MRI using a STIR sequence is an effective radiation free method for examination of children with suspected multifocal bone lesions. MRI showed more lesions than conventional 99mTc-methylene diphosphonate scintigraphy. Therefore, whole-body MRI may be feasible as a screening modality for metastatic and skip lesions in osteosarcoma, PNET, Ewing sarcoma and Langerhans cell histiocytosis in children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, Schober O, Rummeny EJ (2001) Whole-body MR imaging for detection of bone metastases in children and young adults. Am J Roentgenol 177:229–236
Brenner W, Bohuslavizki KH, Eary JF (2003) PET imaging of osteosarcoma. J Nucl Med 44:930–942
Martin W, Delbeke W, Patton J, Sandler M (1996) Detection of malignancies with SPECT versus PET, with 2-[fluorine-18] fluoro-2-dexoy-d-glucose. Radiology 198:225–231
Eustace S, Tello R, De Carvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole-body turbo STIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. Am J Roentgenol 169:1655–1661
Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauber L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129
Haubold-Reuter BG, Duewell S, Schilcher BR, Marincek B, v. Schulthess GK (1993) The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study. Eur J Nucl Med 20:1063–1069
Iizuka-Mikami M, Nagai K, Yoshida K, Sugihara T, Suetsugu Y, Mikami M, Tamada T, Imai S, Kajihara Y, Fukunaga M (2004) Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin’s lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphy. Eur Radiol 14: Feb 18 DOI 10.1007/s0030-003-2209-9
Bender H, Kirst J, Palmedo H (1997) Value of 18-fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast cancer. Anticancer Res 17:1687–1692
Lauenstein TC, Freudenberg LS, Goehde SC, Ruehm SG, Goyen M, Bosk S, Debatin JF, Barkhausen J (2002) Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 12:2091–2099
Kavanagh E, Smith C, Eustace S (2003) Whole-body turbo STIR MR imaging: controversies and avenues for development. Eur Radiol 2196–2205
Algra P, Bloem J, Tissing H, Falke T, Arndt J, Verboom L (1991) Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 11:219–232
Fletcher B (1997) Imaging pediatric bone sarcomas. Radiol Clin N Am 35:1477–1494
Onikul E, Fletcher BD, Parham DM, Chen G (1996). Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma. Am J Roentgenol 167:1211–1215
Moore S, Dawson K (1990) Red and yellow marow in the femor: age related changes in appearance at MRI. Radiology 175:219–223
Mazumdar A, Siegel MJ, Narra V, Luchtman-Jones L (2002) Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. Am J Roentgenol 179:1261–1266
O’Connell MJ, Hargaden, Powell T, Eustace SJ (2002) Whole-body turbo short tau inversion recovery imaging using a moving tabletop. Am J Roentgenol 179:866–868
Hargaden G, O’Connell MJ, Kavanagh E, Powell T, Ward R, Eustace S (2003) Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging. Am J Roentgenol 180:247–252
Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA (2004) Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening bone metastases in patients with breast cancer. Eur Radiol 14:99–105
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mentzel, HJ., Kentouche, K., Sauner, D. et al. Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 14, 2297–2302 (2004). https://doi.org/10.1007/s00330-004-2390-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-004-2390-5